Wake Forest Institute for Regenerative Medicine
GPTKB entity
Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Research_Institute
|
| gptkbp:affiliated_with |
gptkb:Wake_Forest_University
|
| gptkbp:collaborates_with |
various universities
|
| gptkbp:conducts_research_on |
stem cell therapy
tissue engineering organ regeneration |
| gptkbp:director |
gptkb:Dr._Anthony_Atala
|
| gptkbp:focuses_on |
regenerative medicine
|
| gptkbp:founded_in |
gptkb:2004
|
| gptkbp:has_part |
gptkb:Laboratory_Services
clinical trials |
| gptkbp:has_research_focus |
gptkb:gene_therapy
gptkb:cancer_treatment gptkb:Cell gptkb:neurodegenerative_diseases public health organ transplantation patient care patient outcomes wound healing biomaterials cardiovascular diseases musculoskeletal disorders therapeutic development bioengineering health technology assessment healthcare innovation translational medicine clinical applications diabetes treatment spinal cord injuries regenerative therapies clinical trials management 3 D bioprinting |
| https://www.w3.org/2000/01/rdf-schema#label |
Wake Forest Institute for Regenerative Medicine
|
| gptkbp:located_in |
gptkb:Winston-Salem,_North_Carolina
|
| gptkbp:offers_programs_in |
gptkb:medical_research
biomedical engineering |
| gptkbp:publication |
gptkb:academic_journals
|
| gptkbp:receives_funding_from |
government grants
private donations |
| gptkbp:bfsParent |
gptkb:Atala_PRISM
|
| gptkbp:bfsLayer |
6
|